苏轩堂股价下跌3.80%，受技术回调与基本面疲软影响

Company Fundamentals - The company reported revenue of $1.74 million for the fiscal year 2025, representing a year-over-year decline of 9.73% [2] - The net loss for the company was $3.30 million, resulting in a net profit margin of -189.77% [2] - The main business segment, traditional Chinese medicine pieces, accounted for 82.86% of total revenue, but the overall scale remains small and continues to incur losses, leading to a lack of investor confidence in profitability improvement [2] Industry Sector Situation - On the same day, the Nasdaq index fell by 0.25%, while the pharmaceutical sector increased by 1.77% [3] - The company, with a market capitalization of only $0.02 billion, is more susceptible to market sentiment fluctuations [3]